GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (OTCPK:MEDIF) » Definitions » EV-to-FCF

MediPharm Labs (MediPharm Labs) EV-to-FCF : -1.52 (As of Jun. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MediPharm Labs's Enterprise Value is $12.84 Mil. MediPharm Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-8.43 Mil. Therefore, MediPharm Labs's EV-to-FCF for today is -1.52.

The historical rank and industry rank for MediPharm Labs's EV-to-FCF or its related term are showing as below:

MEDIF' s EV-to-FCF Range Over the Past 10 Years
Min: -293.24   Med: -1.55   Max: 0.79
Current: -1.56

During the past 7 years, the highest EV-to-FCF of MediPharm Labs was 0.79. The lowest was -293.24. And the median was -1.55.

MEDIF's EV-to-FCF is ranked worse than
100% of 537 companies
in the Drug Manufacturers industry
Industry Median: 22.9 vs MEDIF: -1.56

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-24), MediPharm Labs's stock price is $0.0558. MediPharm Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.029. Therefore, MediPharm Labs's PE Ratio for today is At Loss.


MediPharm Labs EV-to-FCF Historical Data

The historical data trend for MediPharm Labs's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs EV-to-FCF Chart

MediPharm Labs Annual Data
Trend Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -8.32 -1.79 -1.19 0.22 -0.81

MediPharm Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.70 -1.35 -0.81 -1.55

Competitive Comparison of MediPharm Labs's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediPharm Labs's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's EV-to-FCF falls into.



MediPharm Labs EV-to-FCF Calculation

MediPharm Labs's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12.842/-8.432
=-1.52

MediPharm Labs's current Enterprise Value is $12.84 Mil.
MediPharm Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediPharm Labs  (OTCPK:MEDIF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MediPharm Labs's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0558/-0.029
=At Loss

MediPharm Labs's share price for today is $0.0558.
MediPharm Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.029.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


MediPharm Labs EV-to-FCF Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MediPharm Labs (MediPharm Labs) Business Description

Traded in Other Exchanges
Address
151 John Street, Barrie, ON, CAN, L4N 2L1
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.